BIOLIFE4D Announces Intention to Submit Draft Registration Statement for Underwritten Public Offering of Common Stock
31 déc. 2021 09h15 HE
|
BIOLIFE4D
BUFFALO GROVE, Ill., Dec. 31, 2021 (GLOBE NEWSWIRE) -- BIOLIFE4D Corporation today announced that it intends to submit a draft registration statement on Form S-1 with the U.S. Securities and...
BIOLIFE4D Names Pharmaceutical Veteran Kate Lewis as President
21 sept. 2020 08h00 HE
|
BIOLIFE4D
CHICAGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Kate...
BIOLIFE4D CSO Dr. Ravi Birla Publishes Paper in Prestigious APL Bioengineering Scholarly Journal
27 févr. 2020 08h30 HE
|
BIOLIFE4D
CHICAGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced its Chief Science...
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement
16 sept. 2019 08h00 HE
|
BIOLIFE4D
Company surpasses $3M in accepted investments CHICAGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for...
BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart
09 sept. 2019 08h00 HE
|
BIOLIFE4D
CHICAGO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand
06 sept. 2019 07h30 HE
|
BIOLIFE4D
CHICAGO, Sept. 06, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its...